—m‘

< ‚ª‚ñ‰»Šw—Ö@‚Ɛ¶•¨—Ö@C‘æ‚T”Ł\—˜_‚ÆŽÀÛ >

Cancer Chemotherapy & Biotherapy, 5th ed.

- Principles & Practice

’˜ŽÒ : B.A.Chabner & D.L.Longo
o”ÅŽÐ : LIPPINCOTT WILLIAMS & WILKINS
ISBN : 978-1-60547-431-1
ƒy[ƒW” : 812pp.(154illus.)
o”Å”N : 2011”N

ÝŒÉ‹Í­

’艿32,000‰~(–{‘Ì29,630‰~ { Å)

  • ƒIƒ“ƒ‰ƒCƒ“
  • ¤•ià–¾

–{‘‚Ì“ÁF

RŠàÜ‚Ì‘O—Տ°‚¨‚æ‚їՏ°‚Ì–ò—‚ÉŠÖ‚·‚鑍‡“I‚ȃŠƒtƒ@ƒŒƒ“ƒX‚ªCÅV‚Ì–ò•¨‚ÆŒ»ÝŠJ”­’†‚Ì–ò•¨‚̏î•ñ‚ðŽæ‚è“ü‚ê‚ĉü’ù‚³‚ꂽD“à—e‚Í–ò•¨ŒQ‚²‚Ƃɍ\¬‚³‚êC‚ ‚ç‚ä‚é–ò•¨‚Ɛ¶•¨Šw“I»Ü‚ɂ‚¢‚āCì—p‚̃ƒJƒjƒYƒ€C‘¼‚Ì–ò•¨‚Æ‚Ì‘ŠŒÝì—pC“Ő«C•›ì—pC‘ϐ«‚̃ƒJƒjƒYƒ€C‚Æ‚¢‚Á‚½ÅVî•ñ‚ð’ñ‹Ÿ‚·‚éDŠeÍ‚ł́C•ªŽq‚¨‚æ‚эזEƒŒƒxƒ‹‚Å‚Ì–ò—‚ƍì—p‚̃ƒJƒjƒYƒ€‚ɏd“_‚ð’u‚«C—Տ°‚É‚¨‚¯‚é‹}«‹y‚Ñ’x‰„«‚ÌŠˆ«‚ƓŐ«‚ɂ‚¢‚ďq‚ׂéD“Á’è‚Ì–ò•¨“Š—^ƒXƒPƒWƒ…[ƒ‹‚â–ò•¨•¹—p‚̘_—“Iª‹’‚ð‰ðà‚µC“Á•Ê‚ȏ󋵂ɂ¨‚¯‚é“Š—^—Ê’²ß‚̃KƒCƒhƒ‰ƒCƒ“‚ð’ñŽ¦‚·‚éD
V”ł̏˜˜_‚ɂ́Cˆê”Ê“I‚È–ò•¨Žg—pŒv‰æC–ò•¨‚Ì”­Œ©‚ÆŠJ”­‚̉ȊwCŠàŽ¡—ÖòŠJ”­‚ÌŒoÏ“I‘¤–Ê‚Æ‹K§“I‘¤–ʁC‚¨‚æ‚Ñ–ò•¨“®‘Ô‚ÌŒ´—‚ÉŠÖ‚·‚éƒ^ƒCƒ€ƒŠ[‚ȏî•ñ‚ðŽûÚ‚·‚éD‚Ü‚½C8Í‚ªV‚½‚ɐ݂¯‚ç‚êC20ˆÈã‚̏͂ª‘啝‚ɏ‘‚«‰ü‚ß‚ç‚ꂽD
LWWŽÐ‚Ì–{‘ê—pƒEƒFƒuƒTƒCƒg‚ł́CŒŸõ‹@”\•t‚«‚Ì–{•Ò‘S•¶‚Ɖ摜W‚ðƒIƒ“ƒ‰ƒCƒ“‚Å–³—¿’ñ‹Ÿ‚·‚éD


Table of Contents
SECTION 1: BASIC PRINCIPLES OF CANCER TREATMENT

Clinical Strategies for Cancer Treatment: The Role of Drugs / Target Identification and Drug Discovery / Clinical Drug Development and Approval for Marketing / Principles of Pharmacokinetics / Delivering Anticancer Drugs to Brain Tumor / Pharmacogenetics / Physical Barriers to Drug Delivery
SECTION 2: CYTOTOXIC AGENTS
Antifolates / 5-Fluoropyrimidines / Cytidine Analogues / Purine Antimetabolites / Hydroxyurea / Antimitotic Drugs / Alkylating Agents / Platinum Analogues / Bleomycin and Other Antitumor Antibiotics / Topoisomerase I-Targeting Drugs / Topoisomerase II Inhibitors: Anthracyclines / Topoisomerase II Inhibitors: The Epipodophyllotoxins / Asparaginase
SECTION 3: MOLECULARLY TARGETED THERAPIES
Proteosome Inhibitors / Histone Deacetylase Inhibitors in Oncology / Differentiating Agents / Arsenic Trioxide / Antibodies / Inhibitors of Angiogenesis / Epidermal Growth Factor Receptor Inhibitors / HER2 Inhibitors / Molecular Targeted Drugs / Signaling Inhibitors: IGFR,PI3K Pathway, Embryonic Signaling Inhibitors, and Mitotic Kinase Inhibitors
SECTION 4: IMMUNOLOGIC AGENTS
Cytokine Therapy for Cancer / CancerVaccines / Adoptive Cellular Therapies / Thalidomide and Its Analogs in the Treatment of Hematologic Malignancies, Including Multiple Myeloma, and Solid Tumors
SECTION 5: HORMONAL THERAPY
Hormonal Therapy of Breast Cancer / Hormonal Therapy for Prostate Cancer
SECTION 6: SUPPORTIVE CARE
Drug Therapy of Pain in Cancer Patients / Hematopoietic Growth Factors / Antinausea Medications / Bisphosphonates and Other Bone-Targeted Therapies / Intravenous Access and Catheter Management
SECTION 7: SURVIVORSHIP
Late Effects of Cancer Chemotherapy / Infertility After Cancer Chemotherapy